MedTrace Logo

Femoral Artery Block for Reduction of Tourniquet Induced Hypertension

NCT05954689 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-07-20

No results posted yet for this study

Summary

A randomised controlled trial to assess the impact of femoral artery block on the incidence of tourniquet hypertension in patients receiving cruciate ligament surgery with \> 30 minutes of tourniquet under combined anaesthesia (balanced general anaesthesia and femoral nerve blocks).

Conditions

  • Tourniquets
  • Anesthesia, Conduction
  • Anesthetics, Local
  • Hypertension

Interventions

OTHER

Femoral artery block

Injection on the antero-medial side of the femoral artery of 10mL 0.5% ropivacaine with ultrasound guidance.

Sponsors & Collaborators

  • Hospital da Luz, Portugal

    lead OTHER

Principal Investigators

  • Ana Filipa Duarte · Hospital da Luz, Lisboa

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-10
Primary Completion
2024-02-29
Completion
2024-05-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05954689 on ClinicalTrials.gov